Glenn M Kaye, MD - Medicare Otolaryngology in Bethlehem, PA

Glenn M Kaye, MD is a medicare enrolled "Otolaryngology" physician in Bethlehem, Pennsylvania. He went to University Of Rochester School Of Medicine And Dentistry and graduated in 1987 and has 37 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Specialty Physician Associates, Llc, St Lukes Warren Physician Group Pc and his current practice location is 2851 Baglyos Cir, Suite 201, Bethlehem, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (610) 867-7134.

Glenn M Kaye is licensed to practice in Pennsylvania (license number MD070356L) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1184668634.

Contact Information

Glenn M Kaye, MD
2851 Baglyos Cir, Suite 201,
Bethlehem, PA 18020-8033
(610) 867-7134
(610) 867-7108



Physician's Profile

Full NameGlenn M Kaye
GenderMale
SpecialityOtolaryngology
Experience37 Years
Location2851 Baglyos Cir, Bethlehem, Pennsylvania
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Glenn M Kaye attended and graduated from University Of Rochester School Of Medicine And Dentistry in 1987
  NPI Data:
  • NPI Number: 1184668634
  • Provider Enumeration Date: 06/15/2006
  • Last Update Date: 11/05/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 5799781225
  • Enrollment ID: I20110524000074

Medical Identifiers

Medical identifiers for Glenn M Kaye such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184668634NPI-NPPES
79678OtherNJOPER ENGINEERS LOCAL 825
1441938OtherPAHIGHMARK BLUE SHIELD
1441938OtherPASENIOR BLUE
P3062887OtherPAOXFORD FREEDOM PLAN
1441938OtherPAKEYSTONE HEALTH PLAN CENT
40017782OtherPARAILROAD MEDICARE
50004698OtherPACAPITAL BLUE CROSS
6763353OtherPACIGNA
7774222OtherPAAETNA USHC

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Y00000XOtolaryngology 25MA05907000 (New Jersey)Secondary
207Y00000XOtolaryngology MD070356L (Pennsylvania)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
St Luke's Warren HospitalPhillipsburg, NJHospital
St Luke's Hospital - Anderson CampusEaston, PAHospital
St Luke's Hospital BethlehemBethlehem, PAHospital
St Luke's Hospital - Monroe CampusStroudsburg, PAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Specialty Physician Associates, Llc620401201638
St Lukes Warren Physician Group Pc9739093675314

News Archive

Findings offer novel way for creating drugs to stop mitochondria from destroying cells during stress

Malfunctioning mitochondria — the power plants in cells — are behind the damage caused by strokes, heart attacks, and neurodegenerative diseases, but little has been known about how to stop these reactors from melting down, destroying cells and tissue. Mitochondria also take up calcium, which regulates energy production.

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity's (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to "propose talks to draft global guidelines for doing and communicating work involving dangerous pathogens."

Patients with EGFR-mutated lung cancer benefit more from afatinib as first-line treatment

Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.

UT Southwestern researchers find new potential target for halting tumor growth

UT Southwestern Medical Center researchers have discovered that brain tumors are capable of burning acetate for fuel, providing a new potential target for halting tumor growth.

Protection for nerve cells - eating up defective proteins

Nerve cells in the Central Nervous System can defend against and recover from damage by proteinlike clusters which are associated with neurodegenerative diseases such as Huntington's Chorea.

Read more Medical News

› Verified 1 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Glenn M Kaye allows following entities to bill medicare on his behalf.
Entity NameSt Lukes Physician Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700984622
PECOS PAC ID: 6709798333
Enrollment ID: O20040226000062

News Archive

Findings offer novel way for creating drugs to stop mitochondria from destroying cells during stress

Malfunctioning mitochondria — the power plants in cells — are behind the damage caused by strokes, heart attacks, and neurodegenerative diseases, but little has been known about how to stop these reactors from melting down, destroying cells and tissue. Mitochondria also take up calcium, which regulates energy production.

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity's (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to "propose talks to draft global guidelines for doing and communicating work involving dangerous pathogens."

Patients with EGFR-mutated lung cancer benefit more from afatinib as first-line treatment

Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.

UT Southwestern researchers find new potential target for halting tumor growth

UT Southwestern Medical Center researchers have discovered that brain tumors are capable of burning acetate for fuel, providing a new potential target for halting tumor growth.

Protection for nerve cells - eating up defective proteins

Nerve cells in the Central Nervous System can defend against and recover from damage by proteinlike clusters which are associated with neurodegenerative diseases such as Huntington's Chorea.

Read more Medical News

› Verified 1 days ago

Entity NameSpecialty Physician Associates, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487960639
PECOS PAC ID: 6204012016
Enrollment ID: O20110512000036

News Archive

Findings offer novel way for creating drugs to stop mitochondria from destroying cells during stress

Malfunctioning mitochondria — the power plants in cells — are behind the damage caused by strokes, heart attacks, and neurodegenerative diseases, but little has been known about how to stop these reactors from melting down, destroying cells and tissue. Mitochondria also take up calcium, which regulates energy production.

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity's (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to "propose talks to draft global guidelines for doing and communicating work involving dangerous pathogens."

Patients with EGFR-mutated lung cancer benefit more from afatinib as first-line treatment

Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.

UT Southwestern researchers find new potential target for halting tumor growth

UT Southwestern Medical Center researchers have discovered that brain tumors are capable of burning acetate for fuel, providing a new potential target for halting tumor growth.

Protection for nerve cells - eating up defective proteins

Nerve cells in the Central Nervous System can defend against and recover from damage by proteinlike clusters which are associated with neurodegenerative diseases such as Huntington's Chorea.

Read more Medical News

› Verified 1 days ago

Entity NameStar Community Health Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1033686159
PECOS PAC ID: 7618215237
Enrollment ID: O20190206002009

News Archive

Findings offer novel way for creating drugs to stop mitochondria from destroying cells during stress

Malfunctioning mitochondria — the power plants in cells — are behind the damage caused by strokes, heart attacks, and neurodegenerative diseases, but little has been known about how to stop these reactors from melting down, destroying cells and tissue. Mitochondria also take up calcium, which regulates energy production.

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity's (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to "propose talks to draft global guidelines for doing and communicating work involving dangerous pathogens."

Patients with EGFR-mutated lung cancer benefit more from afatinib as first-line treatment

Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.

UT Southwestern researchers find new potential target for halting tumor growth

UT Southwestern Medical Center researchers have discovered that brain tumors are capable of burning acetate for fuel, providing a new potential target for halting tumor growth.

Protection for nerve cells - eating up defective proteins

Nerve cells in the Central Nervous System can defend against and recover from damage by proteinlike clusters which are associated with neurodegenerative diseases such as Huntington's Chorea.

Read more Medical News

› Verified 1 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Glenn M Kaye is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Glenn M Kaye, MD
2851 Baglyos Cir, Suite 201,
Bethlehem, PA 18020-8033

Ph: (610) 867-7134
Glenn M Kaye, MD
2851 Baglyos Cir, Suite 201,
Bethlehem, PA 18020-8033

Ph: (610) 867-7134

News Archive

Findings offer novel way for creating drugs to stop mitochondria from destroying cells during stress

Malfunctioning mitochondria — the power plants in cells — are behind the damage caused by strokes, heart attacks, and neurodegenerative diseases, but little has been known about how to stop these reactors from melting down, destroying cells and tissue. Mitochondria also take up calcium, which regulates energy production.

NSABB calls for global guidelines for conducting, communicating research involving dangerous pathogens

NewScientist reports on the U.S. National Science Advisory Board for Biosecurity's (NSABB) recommendation that revised versions of two controversial studies on H5N1 avian flu be published in scientific journals, reversing its previous recommendation that the studies only be published if certain details were withheld. According to the news service, dissent among the board members over the issue has prompted the committee to "propose talks to draft global guidelines for doing and communicating work involving dangerous pathogens."

Patients with EGFR-mutated lung cancer benefit more from afatinib as first-line treatment

Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.

UT Southwestern researchers find new potential target for halting tumor growth

UT Southwestern Medical Center researchers have discovered that brain tumors are capable of burning acetate for fuel, providing a new potential target for halting tumor growth.

Protection for nerve cells - eating up defective proteins

Nerve cells in the Central Nervous System can defend against and recover from damage by proteinlike clusters which are associated with neurodegenerative diseases such as Huntington's Chorea.

Read more News

› Verified 1 days ago


Otolaryngology Doctors in Bethlehem, PA

Narges Mazloom, D.O.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3445 High Point Blvd, Suite 400, Bethlehem, PA 18017
Phone: 610-866-5555    Fax: 610-866-3151
Shriya Airen, MD
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017
Phone: 484-503-4005    
Dr. Aaron Jordon Jaworek, MD
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017
Phone: 610-866-5555    Fax: 610-866-3151
Andrew Pestcoe, D.O.
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 2597 Schoenersville Rd Ste 205, Bethlehem, PA 18017
Phone: 610-691-2552    Fax: 610-882-0445
Dr. Ahmad Issam Mahmoud Abualsoud, MBBCH
Otolaryngology
Medicare: Accepting Medicare Assignments
Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017
Phone: 610-866-5555    Fax: 610-866-3151
Maria Katherine Pomponio, MD
Otolaryngology
Medicare: Medicare Enrolled
Practice Location: 3445 High Point Blvd Ste 400, Bethlehem, PA 18017
Phone: 484-503-4005    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.